GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (OTCPK:SEOVF) » Definitions » Quick Ratio

SEOVF (Sernova Biotherapeutics) Quick Ratio : 0.10 (As of Jan. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Sernova Biotherapeutics's quick ratio for the quarter that ended in Jan. 2025 was 0.10.

Sernova Biotherapeutics has a quick ratio of 0.10. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Sernova Biotherapeutics's Quick Ratio or its related term are showing as below:

SEOVF' s Quick Ratio Range Over the Past 10 Years
Min: 0.1   Med: 6.76   Max: 27.94
Current: 0.1

During the past 13 years, Sernova Biotherapeutics's highest Quick Ratio was 27.94. The lowest was 0.10. And the median was 6.76.

SEOVF's Quick Ratio is ranked worse than
96.06% of 1498 companies
in the Biotechnology industry
Industry Median: 3.38 vs SEOVF: 0.10

Sernova Biotherapeutics Quick Ratio Historical Data

The historical data trend for Sernova Biotherapeutics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Quick Ratio Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.25 19.19 10.78 2.19 0.32

Sernova Biotherapeutics Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 0.62 0.32 0.32 0.10

Competitive Comparison of Sernova Biotherapeutics's Quick Ratio

For the Biotechnology subindustry, Sernova Biotherapeutics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Quick Ratio falls into.


;
;

Sernova Biotherapeutics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Sernova Biotherapeutics's Quick Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Quick Ratio (A: Oct. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(4.703-0)/14.549
=0.32

Sernova Biotherapeutics's Quick Ratio for the quarter that ended in Jan. 2025 is calculated as

Quick Ratio (Q: Jan. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.437-0)/14.294
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics  (OTCPK:SEOVF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Sernova Biotherapeutics Quick Ratio Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.